# Takeda Pharmaceutical Co Ltd: Form 6-K, filed Mar 2, 2026

- Company: [Takeda Pharmaceutical Co Ltd](/companies/tak.md) (CIK 1395064)
- Form: 6-K
- Filed: 2026-03-02
- Accepted by EDGAR: Mar 2, 2026, 06:04 ET
- Period: 2026-03-02
- Accession: 0001395064-26-000007
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1395064/000139506426000007/form6k_030226.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1395064/000139506426000007/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1395064/000139506426000007/form6k_030226.htm

Filed Mar 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001395064-26-000007. Last ingested by Listed: Nov 5, 2026, 16:17 ET. No prices; not investment advice.